Mari Eriksson

2PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 31, 2020
A randomized, controlled trial comparing the immunogenecity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.

Mari Eriksson, Helena Käyhty, Heikki Saha

|Mar 08, 2018
Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin.

Mari Eriksson, Janne J Jokinen, Sanni Söderlund

Pageof 1

Frequent Collaborators